Status:
COMPLETED
A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to assess the effect of multiple oral doses of canagliflozin on a single oral dose of warfarin.
Detailed Description
This is an open-label (volunteers will know the names of treatments they are assigned) single-center study of canagliflozin (JNJ-28431754) and warfarin in healthy adult volunteers. Canagliflozin is a ...
Eligibility Criteria
Inclusion
- Healthy volunteers with a body mass index between 18 and 30 kg/m
Exclusion
- Any blood coagulation disorder determined to be clinically relevant by the Investigator
- Medications known to affect coagulation taken within 7 to 14 days of study entry
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01195324
Start Date
September 1 2010
End Date
December 1 2010
Last Update
May 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Merksem, Belgium